🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Neuromodulation With Spinal Stimulation Methods

RecruitingNAAges 18 Years - 65 YearsAllUniversity of Manitoba
NCT06272279 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This is a pilot research study to test the protocols needed for transcutaneous spinal electrical stimulation in persons living with spinal cord injury (SCI). Up to 24 participants will be enrolled. A variety of stimulation parameters and outcome measures will be assessed.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * spinal cord injury C4 to L4 * ability to understand and follow directions Exclusion Criteria: * history of seizures, head injury, concussion, unexplained loss of consciousness or if they lived with an implanted cochlear stimulator, brain/neurostimulator, cardiac pacemaker, medication infusion device or live with metal implants in their body or if they are pregnant.
💊

What it tests

  • spinal stimulation-DCS
  • spinal stimulation-sham DCS
  • spinal stimulation-EPS
  • sham spinal stimulation-EPS
📍

Where

2 sites
University of Manitoba
Winnipeg, Canada
University of Manitoba
Winnipeg, Canada
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy